RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by Surgery
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This pilot phase II trial is studying how well RO4929097 works in treating patients with
stage III, or stage IV melanoma that can be removed by surgery. RO4929097 may stop the growth
of tumor cells by blocking some of the enzymes needed for cell growth